Reaction
Plasmacytoma reporting signals
As of the last recalculation, Plasmacytoma appears in 1,854 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is BORTEZOMIB (PRR 83.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bortezomib | 493 | 83.9 | 84.4 |
| Carfilzomib | 188 | 82.9 | 83.5 |
| Daratumumab | 237 | 76.2 | 76.7 |
| Thalidomide | 212 | 73.1 | 73.5 |
| Dexamethasone 1.5 Mg | 738 | 46.3 | 46.4 |
| Dexamethasone | 738 | 45.7 | 45.8 |
| Melphalan | 81 | 41.8 | 41.9 |
| Melphalan Hydrochloride | 88 | 41.3 | 41.5 |
| Pomalidomide | 301 | 39.1 | 39.2 |
| Lenalidomide | 728 | 31.2 | 31.3 |
| Ixazomib | 76 | 30.9 | 31.0 |
| Selinexor | 20 | 26.2 | 26.3 |
| Bendamustine Hcl | 23 | 16.8 | 16.9 |
| Acyclovir | 154 | 16.4 | 16.4 |
| Cyclophosphamide Injection, Solution | 205 | 14.5 | 14.5 |
| Cyclophosphamide | 205 | 14.5 | 14.5 |
| Cyclophosphamide For Injection | 205 | 14.5 | 14.5 |
| Chlorhexidine Gluconate | 11 | 13.6 | 13.6 |
| Etoposide | 61 | 9.6 | 9.6 |
| Doxorubicin | 71 | 9.3 | 9.3 |
| Dexamethasone Sodium Phosphate | 8 | 8.9 | 8.9 |
| Erythropoietin | 16 | 8.8 | 8.8 |
| Gentamicin | 10 | 8.6 | 8.6 |
| Prochlorperazine Maleate | 7 | 8.6 | 8.6 |
| Cisplatin | 54 | 8.0 | 8.0 |
| Timolol Maleate | 7 | 8.0 | 8.0 |
| Doxorubicin Hydrochloride | 22 | 7.6 | 7.6 |
| Filgrastim | 24 | 7.2 | 7.2 |
| Valacyclovir | 26 | 7.1 | 7.1 |
| Prochlorperazine | 17 | 6.9 | 6.9 |
| Fludarabine Phosphate | 23 | 6.6 | 6.6 |
| Bendamustine Hydrochloride | 7 | 6.6 | 6.6 |
| Olaparib | 6 | 3.2 | 3.2 |